Update on pathogenesis, markers and management of diabetic nephropathy.

Abstract:

:Experimental animal models and cell culture techniques, highlighting the central role of glucose metabolism, have provided important insight into the pathogenesis of diabetic nephropathy. Microalbuminuria and other candidate phenotypic or genotypic markers for the early onset of disease are discussed. Management recommendations center around strict glycemic control and the normalization of blood pressure by angiotensin-converting enzyme inhibitors.

authors

Mogyorósi A,Ziyadeh FN

doi

10.1097/00041552-199605000-00010

subject

Has Abstract

pub_date

1996-05-01 00:00:00

pages

243-53

issue

3

eissn

1062-4821

issn

1473-6543

journal_volume

5

pub_type

杂志文章,评审
  • Hypertension in end-stage renal disease patients.

    abstract::The prevalence of hypertension is extremely high in end-stage renal disease, and is a probable contributor to the epidemic of cardiovascular disease in end-stage renal disease. However, the paucity of prospective, randomized clinical trials makes it difficult to precisely define treatment strategies. Therefore, at pre...

    journal_title:Current opinion in nephrology and hypertension

    pub_type: 杂志文章,评审

    doi:10.1097/00041552-200005000-00012

    authors: Zager P,Nikolic J,Raj DS,Tzamaloukas A,Campbell M

    更新日期:2000-05-01 00:00:00

  • Structural biology: a high-tech tool for biomedical research.

    abstract:PURPOSE OF REVIEW:Structural biology is one of the most informative disciplines available to biochemical research. It unites technologies that can reveal high-resolution (often atomic) details of the inner workings of biochemical systems. These insights are crucial for an understanding of basic life processes, such as ...

    journal_title:Current opinion in nephrology and hypertension

    pub_type: 杂志文章,评审

    doi:10.1097/00041552-200307000-00012

    authors: Machius M

    更新日期:2003-07-01 00:00:00

  • Iothalamate clearance and its use in large-scale clinical trials.

    abstract::Several recently completed or ongoing large-scale clinical trials, including the Modification of Diet in Renal Disease Study, the Diabetes Control and Complications Trial, and the African-American Study of Kidney Disease and Hypertension, have all chosen the renal clearance of sodium 125I-iothalmate to monitor renal d...

    journal_title:Current opinion in nephrology and hypertension

    pub_type: 杂志文章,评审

    doi:10.1097/00041552-199511000-00010

    authors: Hall PM,Rolin H

    更新日期:1995-11-01 00:00:00

  • Triumph and tragedy: anemia management in chronic kidney disease.

    abstract:PURPOSE OF REVIEW:Recent trial data have resulted in a reevaluation of the management of anemia in chronic kidney disease, including the use of erythropoiesis-stimulating agents, intravenous iron, and novel pharmaceuticals. In this review, we evaluate the latest research on anemia management in chronic kidney disease. ...

    journal_title:Current opinion in nephrology and hypertension

    pub_type: 杂志文章,评审

    doi:10.1097/MNH.0b013e32830c488d

    authors: Novak JE,Szczech LA

    更新日期:2008-11-01 00:00:00

  • Direct measurement of sympathetic activity: new insights into disordered blood pressure regulation in chronic renal failure.

    abstract::The ability to record sympathetic nerve activity in conscious human subjects using intraneural microelectrodes (microneurography) has proven to be a powerful clinical research tool, which has shed new light on the pathophysiology of important blood pressure problems as exemplified in studies of patients with chronic r...

    journal_title:Current opinion in nephrology and hypertension

    pub_type: 杂志文章,评审

    doi:10.1097/00041552-199411000-00014

    authors: Hansen J,Victor RG

    更新日期:1994-11-01 00:00:00

  • Safety of intravenous iron use in chronic kidney disease.

    abstract:PURPOSE OF REVIEW:Iron deficiency anaemia (IDA) is common and associated with fatigue, reduced quality of life and poorer clinical outcomes. Treatment with oral iron is often inadequate and international guidelines recommend intravenous (i.v.) iron as the preferred option for the treatment of IDA in certain clinical si...

    journal_title:Current opinion in nephrology and hypertension

    pub_type: 杂志文章,评审

    doi:10.1097/MNH.0000000000000263

    authors: Kalra PA,Bhandari S

    更新日期:2016-11-01 00:00:00

  • Bone biopsy in renal osteodystrophy: continued insights into a complex disease.

    abstract:PURPOSE OF REVIEW:The pathogenesis and optimal therapy of renal bone disease remains poorly understood in chronic kidney disease (CKD) and dialysis patients. Bone biopsy is thus far the only window into cellular and molecular events in bone. This review will focus on recent insights into the pathophysiology of renal bo...

    journal_title:Current opinion in nephrology and hypertension

    pub_type: 杂志文章,评审

    doi:10.1097/MNH.0b013e32835dda01

    authors: Christov M,Pereira R,Wesseling-Perry K

    更新日期:2013-03-01 00:00:00

  • Modeling hypercalciuria in the genetic hypercalciuric stone-forming rat.

    abstract:PURPOSE OF REVIEW:In this review, we discuss how the genetic hypercalciuric stone-forming (GHS) rats, which closely model idiopathic hypercalciuria and stone formation in humans, provide insights into the pathophysiology and consequences of clinical hypercalciuria. RECENT FINDINGS:Hypercalciuria in the GHS rats is due...

    journal_title:Current opinion in nephrology and hypertension

    pub_type: 杂志文章,评审

    doi:10.1097/MNH.0000000000000130

    authors: Frick KK,Krieger NS,Bushinsky DA

    更新日期:2015-07-01 00:00:00

  • Molecular pathophysiology of SLC4 bicarbonate transporters.

    abstract:PURPOSE OF REVIEW:Acid-base (H and HCO3) transport in the kidney is crucial for maintaining blood pH, cellular pH and excreting metabolic acid. HCO3 transport in the kidney is mediated by HCO3 transporter proteins which occur in two gene families in humans, vertebrates and invertebrates (SLC4 and SLC26). Since SLC26 tr...

    journal_title:Current opinion in nephrology and hypertension

    pub_type: 杂志文章,评审

    doi:10.1097/01.mnh.0000168333.01831.2c

    authors: Romero MF

    更新日期:2005-09-01 00:00:00

  • Methylglyoxal stress, the glyoxalase system, and diabetic chronic kidney disease.

    abstract:PURPOSE OF REVIEW:Chronic kidney disease (CKD) remains a serious diabetic complication despite the use of widely employed interventions such as angiotensin-converting enzyme inhibitors and glucose-lowering treatments. Accumulation of methylglyoxal, a highly reactive glucose metabolite and a major precursor in the forma...

    journal_title:Current opinion in nephrology and hypertension

    pub_type: 杂志文章,评审

    doi:10.1097/MNH.0000000000000465

    authors: Hanssen NMJ,Stehouwer CDA,Schalkwijk CG

    更新日期:2019-01-01 00:00:00

  • Advances in the management of hyperkalemia in chronic kidney disease.

    abstract:PURPOSE OF REVIEW:Patients with chronic kidney disease (CKD) have an increased risk of hyperkalemia that increases both short-term and long-term mortality. Historically, managing hyperkalemia has relied upon dietary modifications, augmentation of urinary potassium excretion and enhanced enteral potassium elimination. T...

    journal_title:Current opinion in nephrology and hypertension

    pub_type: 杂志文章,评审

    doi:10.1097/MNH.0000000000000320

    authors: Cowan AC,Gharib EG,Weir MA

    更新日期:2017-05-01 00:00:00

  • Measurement of insulin resistance in chronic kidney disease.

    abstract:PURPOSE OF REVIEW:Insulin resistance is a known complication of end-stage renal disease that also appears to be present in earlier stages of chronic kidney disease (CKD). It is a risk factor for cardiovascular disease and an important potential therapeutic target in this population. Measurement of insulin resistance is...

    journal_title:Current opinion in nephrology and hypertension

    pub_type: 杂志文章,评审

    doi:10.1097/MNH.0b013e32834b23c1

    authors: Pham H,Utzschneider KM,de Boer IH

    更新日期:2011-11-01 00:00:00

  • Genetic variants of mineral metabolism in health and disease.

    abstract:PURPOSE OF REVIEW:Disturbances in mineral metabolism are common among individuals with chronic kidney disease and have consistently been associated with cardiovascular and bone disease. The current review aims to describe the current knowledge of the genetic aspects of mineral metabolism disturbances and to suggest dir...

    journal_title:Current opinion in nephrology and hypertension

    pub_type: 杂志文章

    doi:10.1097/MNH.0000000000000612

    authors: Robinson-Cohen C

    更新日期:2020-07-01 00:00:00

  • Carboxyl-terminal parathyroid hormone fragments: role in parathyroid hormone physiopathology.

    abstract:PURPOSE OF REVIEW:Carboxyl-terminal parathyroid hormone (C-PTH) fragments constitute 80% of circulating PTH. Since the first 34 amino acids of the PTH structure are sufficient to explain PTH classical biological effects on the type I PTH/PTHrP receptor and since C-PTH fragments do not bind to this receptor, they have l...

    journal_title:Current opinion in nephrology and hypertension

    pub_type: 杂志文章,评审

    doi:10.1097/01.mnh.0000172718.49476.64

    authors: D'Amour P,Brossard JH

    更新日期:2005-07-01 00:00:00

  • Aldosterone blockade in chronic kidney disease: can it improve outcome?

    abstract:PURPOSE OF THIS REVIEW:The purpose of this review is to explain the rationale and limitations for use of mineralocorticoid receptor blockers (MRBs) for the treatment of chronic kidney disease (CKD) and its complications. RECENT FINDINGS:Recent studies in animal models of CKD demonstrate that blockade of the mineraloco...

    journal_title:Current opinion in nephrology and hypertension

    pub_type: 杂志文章,评审

    doi:10.1097/MNH.0b013e32833ce6d5

    authors: Toto RD

    更新日期:2010-09-01 00:00:00

  • Conservative vs. preservative management of chronic kidney disease: similarities and distinctions.

    abstract:PURPOSE OF REVIEW:Dialysis has been the prevailing treatment paradigm in advanced chronic kidney disease (CKD) for patients ineligible for or unlikely to receive kidney transplantation. As dialysis may neither offer survival benefit nor improved quality of life in certain groups, there has been increasing interest in c...

    journal_title:Current opinion in nephrology and hypertension

    pub_type: 杂志文章

    doi:10.1097/MNH.0000000000000573

    authors: Rhee CM,Nguyen DV,Nyamathi A,Kalantar-Zadeh K

    更新日期:2020-01-01 00:00:00

  • Diagnosis and management of iron deficiency in chronic dialysis patients.

    abstract::Tests have become available that not only give an index of iron stores and availability but also provide an integrated assessment of the efficacy of its utilization. This has allowed the revision of previously accepted criteria of iron deficiency as well as the most appropriate strategies for iron administration. By o...

    journal_title:Current opinion in nephrology and hypertension

    pub_type: 杂志文章,评审

    doi:10.1097/00041552-200011000-00013

    authors: van Zyl-Smit R

    更新日期:2000-11-01 00:00:00

  • Benefits of dietary sodium restriction in the management of chronic kidney disease.

    abstract:PURPOSE OF REVIEW:To evaluate the role of restricting dietary sodium intake in chronic kidney disease (CKD) and its complications. RECENT FINDINGS:A consistent line of evidence shows that high dietary sodium intake is a determinant of therapy resistance to blockade of the renin-angiotensin-aldosterone system (RAAS). A...

    journal_title:Current opinion in nephrology and hypertension

    pub_type: 杂志文章,评审

    doi:10.1097/MNH.0b013e3283312fc8

    authors: Krikken JA,Laverman GD,Navis G

    更新日期:2009-11-01 00:00:00

  • The role of incretins in salt-sensitive hypertension: the potential use of dipeptidyl peptidase-IV inhibitors.

    abstract:PURPOSE OF REVIEW:Incretin mimetics, such as glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), as well as dipeptidyl peptidase-IV (DPP-IV) inhibitors, are used in the treatment of type 2 diabetes mellitus (T2DM). In addition to stimulating insulin secretion from pancreatic β cells,...

    journal_title:Current opinion in nephrology and hypertension

    pub_type: 杂志文章,评审

    doi:10.1097/MNH.0b013e328349af9d

    authors: Tanaka T,Nangaku M,Nishiyama A

    更新日期:2011-09-01 00:00:00

  • Regulation of parathyroid cell proliferation.

    abstract::The parathyroid normally has very few cells in mitosis but it retains the potential to proliferate. In-vivo studies in rats have demonstrated that hypocalcaemia and high serum phosphate both lead to an increase in the number of proliferating cells, which is relevant to the increased parathyroid cell proliferation in c...

    journal_title:Current opinion in nephrology and hypertension

    pub_type: 杂志文章,评审

    doi:10.1097/00041552-199707000-00004

    authors: Silver J,Sela SB,Naveh-Many T

    更新日期:1997-07-01 00:00:00

  • Imaging of renal fibrosis.

    abstract:PURPOSE OF REVIEW:Fibrosis is an important biomarker of chronic kidney injury, and a powerful predictor of renal outcome. Currently, the only method for measuring fibrotic burden is histologic analysis, which requires a kidney biopsy in humans, or kidney removal in animal models. These requirements have not only hinder...

    journal_title:Current opinion in nephrology and hypertension

    pub_type: 杂志文章

    doi:10.1097/MNH.0000000000000650

    authors: Hysi E,Yuen DA

    更新日期:2020-11-01 00:00:00

  • Extrarenal effects of aldosterone.

    abstract:PURPOSE OF REVIEW:The renal distal tubule has been considered for a long time as the main cellular target of aldosterone, where the hormone enhances sodium reabsorption and potassium secretion. However, other cell types in nonepithelial tissues, such as the heart, the vessels, adipose tissue, and macrophages, are now a...

    journal_title:Current opinion in nephrology and hypertension

    pub_type: 杂志文章,评审

    doi:10.1097/MNH.0b013e32834fb25b

    authors: Nguyen Dinh Cat A,Jaisser F

    更新日期:2012-03-01 00:00:00

  • Control of serum phosphorus: implications for coronary artery calcification and calcific uremic arteriolopathy (calciphylaxis).

    abstract::There is mounting evidence that elevated serum phosphorus is an important cardiovascular risk factor in patients with end stage renal disease. Recent work has shown that vascular smooth muscle cells have the ability to undergo osteoblastic differentiation and produce an environment conducive to mineralization. Serum p...

    journal_title:Current opinion in nephrology and hypertension

    pub_type: 杂志文章,评审

    doi:10.1097/00041552-200111000-00003

    authors: Block GA

    更新日期:2001-11-01 00:00:00

  • The balance of angiotensin II and nitric oxide in kidney diseases.

    abstract:PURPOSE OF REVIEW:The imbalances in the activities of various components of the neurohormonal system that maintain renal homeostasis may have important implications in pathophysiology. This review aims to examine the evidence for disparities between angiotensin II and nitric oxide in acute and chronic kidney diseases. ...

    journal_title:Current opinion in nephrology and hypertension

    pub_type: 杂志文章,评审

    doi:10.1097/MNH.0b013e3282f29a8b

    authors: Singh P,Deng A,Weir MR,Blantz RC

    更新日期:2008-01-01 00:00:00

  • PPARγ as a therapeutic target in diabetic nephropathy and other renal diseases.

    abstract:PURPOSE OF REVIEW:Peroxisome proliferator-activated receptor gamma (PPARγ) is a ligand-activated nuclear transcription factor that regulates many important physiological processes including glucose and lipid metabolism, energy homeostasis, cell proliferation, inflammation, immunity and reproduction. The current review ...

    journal_title:Current opinion in nephrology and hypertension

    pub_type: 杂志文章,评审

    doi:10.1097/MNH.0b013e32834de526

    authors: Yang J,Zhou Y,Guan Y

    更新日期:2012-01-01 00:00:00

  • Tubulointerstitial disease: role of ischemia and microvascular disease.

    abstract:PURPOSE OF REVIEW:Tubulointerstitial injury is characteristic of aging-associated renal injury and progressive renal disease. Salt-sensitive hypertension is also associated with tubulointerstitial inflammation, especially when accompanied by microvascular disease. Here we summarize recent studies on the pathogenesis an...

    journal_title:Current opinion in nephrology and hypertension

    pub_type: 杂志文章,评审

    doi:10.1097/00041552-200305000-00003

    authors: Nakagawa T,Kang DH,Ohashi R,Suga S,Herrera-Acosta J,Rodriguez-Iturbe B,Johnson RJ

    更新日期:2003-05-01 00:00:00

  • Antihypertensive therapy in the obese hypertensive patient.

    abstract:PURPOSE OF REVIEW:Obesity is becoming recognized as one of the most important risk factors for the development of hypertension. The purpose of the review is to examine the latest evidence linking hypertension to obesity, summarize the benefits of weight reduction and present results of recent clinical trials evaluating...

    journal_title:Current opinion in nephrology and hypertension

    pub_type: 杂志文章,评审

    doi:10.1097/01.mnh.0000242173.14082.dc

    authors: Chrostowska M,Szczech R,Narkiewicz K

    更新日期:2006-09-01 00:00:00

  • Role of microRNAs in aldosterone signaling.

    abstract:PURPOSE OF REVIEW:The review describes studies investigating the role of microRNAs in the signaling pathway of the mineralocorticoid hormone, aldosterone. RECENT FINDINGS:Emerging evidence indicates that aldosterone alters the expression of microRNAs in target tissues thereby modulating the expression of key regulator...

    journal_title:Current opinion in nephrology and hypertension

    pub_type: 杂志文章,评审

    doi:10.1097/MNH.0000000000000440

    authors: Butterworth MB

    更新日期:2018-09-01 00:00:00

  • Visit-to-visit blood pressure variability and risk for progression of cardiovascular and renal diseases.

    abstract:PURPOSE OF REVIEW:Recent data have highlighted the shortcomings of the usual blood pressure hypothesis in posthoc analyses of randomized controlled trials led in populations at high cardiovascular risk and have emphasized the importance of an increased visit-to-visit variability of blood pressure in predicting cardiova...

    journal_title:Current opinion in nephrology and hypertension

    pub_type: 杂志文章,评审

    doi:10.1097/MNH.0b013e32835b489f

    authors: Rossignol P,Kessler M,Zannad F

    更新日期:2013-01-01 00:00:00

  • Treatment of renal anemia with recombinant human erythropoietin.

    abstract::It has been 6 years since the first reports of the use of recombinant human erythropoietin for the treatment of renal anemia appeared in the medical literature. During this period, erythropoietin has become established as a safe and highly effective therapy, and it is currently being evaluated for other nonrenal types...

    journal_title:Current opinion in nephrology and hypertension

    pub_type: 杂志文章,评审

    doi:10.1097/00041552-199212000-00005

    authors: Macdougall IC

    更新日期:1992-12-01 00:00:00